Laboratorios Farmaceuticos Rovi, S.A. (LABFF)
USD 90.61
(0.0%)
USD 90.61
(0.0%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | 113.24 Million | 237.6 Million | 149.44 Million | 46.87 Million | -9.04 Million | 8.53 Million |
| Net Income | 220.4 Million | 257.96 Million | 182.62 Million | 72.58 Million | 41.88 Million | 16.68 Million |
| Depreciation & Amortization | 24.33 Million | 22.87 Million | 21.36 Million | 19.59 Million | 18.21 Million | 12.04 Million |
| Deferred income taxes | - | - | 13.71 Million | - | - | - |
| Stock-based compensation | - | - | 1.4 Million | - | - | - |
| Change in working capital | -34.44 Million | -56.97 Million | -64.03 Million | -63.75 Million | -63.66 Million | -24.43 Million |
| Other non-cash items | -97.04 Million | 13.73 Million | -5.63 Million | 18.45 Million | -5.47 Million | 4.24 Million |
| Investing Cash Flow | -52.02 Million | -57.15 Million | -40.83 Million | -39.62 Million | -40.47 Million | -26.24 Million |
| Investments in PPE | -55.18 Million | -51.38 Million | -40.94 Million | -39.69 Million | -40.52 Million | -26.45 Million |
| Acquisitions | 1.2 Million | 669 Thousand | 33 Thousand | 63 Thousand | 2000.00 | 50 Thousand |
| Investment purchases | 1.39 Million | -5.87 Million | - | - | - | - |
| Sales/Maturities of investments | 88 Thousand | 20 Thousand | - | - | - | 50 Thousand |
| Other Investing Activities | 478 Thousand | -585 Thousand | 68 Thousand | 4000.00 | 51 Thousand | 167 Thousand |
| Financing Cash Flow | -160.84 Million | -154.53 Million | -62.72 Million | -21.51 Million | 21.43 Million | 72.52 Million |
| Debt repayment | -13.65 Million | -6.76 Million | -6.19 Million | -13.17 Million | -21.24 Million | -16.23 Million |
| Dividends payments | -69.04 Million | -51 Million | -21.13 Million | -9.7 Million | -4.42 Million | -5.95 Million |
| Common Stock Repurchased | -133.9 Million | -177 Million | -78.78 Million | -37.25 Million | -4.71 Million | -1.13 Million |
| Common Stock Issuance | 52.63 Million | 77.76 Million | 42.32 Million | 37.48 Million | 4.87 Million | 986 Thousand |
| Other Financing Activities | 3.12 Million | 2.48 Million | 1.05 Million | 1.13 Million | 46.94 Million | 94.85 Million |
| Accounts receivables | 19.47 Million | -26.82 Million | -74.18 Million | 7.46 Million | -20.4 Million | -9.6 Million |
| Accounts payables | -19.47 Million | 41.67 Million | 35.35 Million | -811 Thousand | 23.95 Million | 6.54 Million |
| Inventory | -29.29 Million | -71.59 Million | -23.42 Million | -70.39 Million | -67.22 Million | -21.34 Million |
| Other working capital | -5.15 Million | -234 Thousand | -1.77 Million | -10 Thousand | 18 Thousand | -3.08 Million |
| Cash at beginning of period | 124.94 Million | 99.03 Million | 53.16 Million | 67.42 Million | 95.51 Million | 40.7 Million |
| Cash at end of period | 25.32 Million | 124.94 Million | 99.03 Million | 53.16 Million | 67.42 Million | 95.51 Million |
| Capital Expenditure | -55.18 Million | -51.38 Million | -40.94 Million | -39.69 Million | -40.52 Million | -26.45 Million |
| Effect of forex changes on cash | - | -1000.00 | - | - | - | - |
| Net cash flow / Change in cash | -99.62 Million | 25.91 Million | 45.87 Million | -14.26 Million | -28.08 Million | 54.81 Million |
| Free Cash Flow | 58.06 Million | 186.21 Million | 108.5 Million | 7.18 Million | -49.56 Million | -17.92 Million |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | 37.13 Million | 19 Million | 66.23 Million | 220.4 Million | 68.34 Million | 24.66 Million |
| Depreciation & Amortization | 6.82 Million | 6.62 Million | 6.51 Million | 24.33 Million | 5.95 Million | 6.04 Million |
| Deferred income taxes | - | - | - | - | - | - |
| Stock-based compensation | - | - | - | - | - | - |
| Change in working capital | -5.77 Million | -13.6 Million | 33.07 Million | -34.44 Million | -60.06 Million | 9.08 Million |
| Other non-cash items | 92 Thousand | 55 Thousand | -44.79 Million | -97.04 Million | -14.54 Million | -11.76 Million |
| Investing Cash Flow | -9.57 Million | -9.15 Million | -26.28 Million | -52.02 Million | -8.36 Million | -12.55 Million |
| Investments in PPE | -9.68 Million | -8.99 Million | -28.39 Million | -55.18 Million | -8.62 Million | -13.25 Million |
| Acquisitions | - | -255 Thousand | 1.8 Million | 1.2 Million | 239 Thousand | - |
| Investment purchases | - | - | -1.8 Million | 1.39 Million | -600 Thousand | - |
| Sales/Maturities of investments | - | 80 Thousand | 1.8 Million | 88 Thousand | 78 Thousand | 10 Thousand |
| Other Investing Activities | -406 Thousand | -298 Thousand | 315 Thousand | 478 Thousand | 541 Thousand | 696 Thousand |
| Financing Cash Flow | 26.86 Million | -18.62 Million | -65.8 Million | -160.84 Million | -88.75 Million | -3.12 Million |
| Debt repayment | -37.87 Million | -16.13 Million | -3.8 Million | -13.65 Million | -3.03 Million | -3.22 Million |
| Dividends payments | - | - | - | -69.04 Million | -69.04 Million | - |
| Common Stock Repurchased | -17.45 Million | -34.65 Million | -62.96 Million | -133.9 Million | -22.19 Million | -19 Million |
| Common Stock Issuance | 4.09 Million | - | -4000.00 | 52.63 Million | 4.01 Million | 19.1 Million |
| Other Financing Activities | 6.44 Million | -99 Thousand | 999 Thousand | 3.12 Million | 1.6 Million | 9000.00 |
| Accounts receivables | 7.94 Million | 19.09 Million | -22.24 Million | 19.47 Million | -12.46 Million | 28.65 Million |
| Accounts payables | - | - | 22.24 Million | -19.47 Million | -30.56 Million | 8.23 Million |
| Inventory | -18.76 Million | 2.7 Million | 23.95 Million | -29.29 Million | -13.18 Million | -27.8 Million |
| Other working capital | -1.25 Million | -101 Thousand | 9.11 Million | -5.15 Million | -3.84 Million | -3.81 Million |
| Cash at beginning of period | 13.08 Million | 25.32 Million | 56.37 Million | 124.94 Million | 153.81 Million | 141.46 Million |
| Cash at end of period | 44.57 Million | 13.08 Million | 25.32 Million | 25.32 Million | 56.37 Million | 153.81 Million |
| Capital Expenditure | -9.68 Million | -8.99 Million | -28.39 Million | -55.18 Million | -8.62 Million | -13.25 Million |
| Effect of forex changes on cash | - | - | - | - | - | - |
| Net cash flow / Change in cash | 31.49 Million | -12.23 Million | -31.05 Million | -99.62 Million | -97.43 Million | 12.35 Million |
| Free Cash Flow | 4.52 Million | 6.55 Million | 32.63 Million | 58.06 Million | -8.93 Million | 14.77 Million |
KALAMANDIR
TM
AMRT
LGBBROSLTD
VERX
KPTSF